1. Home
  2. ENVB vs WTO Comparison

ENVB vs WTO Comparison

Compare ENVB & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • WTO
  • Stock Information
  • Founded
  • ENVB 1994
  • WTO 2008
  • Country
  • ENVB United States
  • WTO China
  • Employees
  • ENVB N/A
  • WTO N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • WTO Consumer Electronics/Appliances
  • Sector
  • ENVB Health Care
  • WTO Technology
  • Exchange
  • ENVB Nasdaq
  • WTO Nasdaq
  • Market Cap
  • ENVB 3.1M
  • WTO 3.2M
  • IPO Year
  • ENVB N/A
  • WTO 2021
  • Fundamental
  • Price
  • ENVB $1.15
  • WTO $1.06
  • Analyst Decision
  • ENVB Strong Buy
  • WTO
  • Analyst Count
  • ENVB 1
  • WTO 0
  • Target Price
  • ENVB $10.00
  • WTO N/A
  • AVG Volume (30 Days)
  • ENVB 179.6K
  • WTO 70.6K
  • Earning Date
  • ENVB 08-11-2025
  • WTO 08-12-2025
  • Dividend Yield
  • ENVB N/A
  • WTO N/A
  • EPS Growth
  • ENVB N/A
  • WTO N/A
  • EPS
  • ENVB N/A
  • WTO N/A
  • Revenue
  • ENVB N/A
  • WTO $32,309,502.00
  • Revenue This Year
  • ENVB N/A
  • WTO N/A
  • Revenue Next Year
  • ENVB N/A
  • WTO N/A
  • P/E Ratio
  • ENVB N/A
  • WTO N/A
  • Revenue Growth
  • ENVB N/A
  • WTO 47.36
  • 52 Week Low
  • ENVB $1.01
  • WTO $0.75
  • 52 Week High
  • ENVB $8.95
  • WTO $622.50
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 35.60
  • WTO 45.31
  • Support Level
  • ENVB $1.18
  • WTO $1.14
  • Resistance Level
  • ENVB $1.26
  • WTO $1.26
  • Average True Range (ATR)
  • ENVB 0.08
  • WTO 0.11
  • MACD
  • ENVB -0.02
  • WTO -0.00
  • Stochastic Oscillator
  • ENVB 3.10
  • WTO 16.67

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; and Do, as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: